Clinical Trial: OVV-01 Intravenous and Intratumoral Injection Combined With AK112 for the Treatment of Advanced Solid Tumors

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07650825) titled 'OVV-01 Intravenous and Intratumoral Injection Combined With AK112 for the Treatment of Advanced Solid Tumors' on March 28.

Brief Summary: This study is an open-label, multiple-route-of-administration dose-escalation clinical trial designed to evaluate the safety and preliminary efficacy of OVV-01 injection administered intravenously or intravenously plus intratumorally, either as monotherapy or in combination with AK112 injection, in subjects with advanced solid tumors.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: OVV-01

OVV-01 is administered twice every two weeks...